solventum thermo - Search News

Solventum Stock Jumps

Solventum Stock Jumps After $4.1B Deal With Thermo Fisher

Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion.Solventum Chief Executive Officer Bryan Hanson said the move is part of a transformation plan for the company,

Star Tribune · 2d

Minnesota's Solventum sells purification business to Thermo Fisher for $4.1 billion

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said in a news release that the sale,

GEN · 2h

Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Solv, Q4 and EPS Beats

The Motley Fool on MSN · 6h

Solventum: Q4 EPS Beats, Cash Flow Dips

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Zacks.com on MSN · 3h

SOLV Stock Down Despite Q4 Earnings & Revenues Beat Estimates

Solventum SOLV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.41, which beat the Zacks Consensus Estimate of $1.31 by 7.6%. The bottom line declined 35% year over year. GAAP EPS in the quarter was 17 cents,

StockStory.org on MSN · 21h

Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates

Healthcare solutions provider Solventum (NYSE:SOLV) reported in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per share was 7.8% above analysts’ consensus estimates.

MM&M2h

Rx Rundown: Thermo Fisher Scientific, the CDC, Eli Lilly and more

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Trian ‘commends’ Solventum on Filtration unit sale, sees cost cut opportunities

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Solventum Stock Jumps

Solv, Q4 and EPS Beats

Trending now